Clinical Trial Update: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use [Phase 2]

View source ↗

Summary

A Phase II randomized trial evaluating augmented reality gaming to reduce postoperative opioid use in opioid-tolerant pediatric cancer patients undergoing surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer | Phase 2 | Status: WITHDRAWN